FOSPET predicts VA

Article

Foveal outer segment/pigment epithelial thickness (FOSPET) is significantly thinner in patients with retinitis pigmentosa (RP) than in normal eyes and also shows correlation in logMAR visual acuity (VA), indicating it may be a predictor of VA in RP, according to a study published in the December 2006 issue of the American Journal of Ophthalmology.

Foveal outer segment/pigment epithelial thickness (FOSPET) is significantly thinner in patients with retinitis pigmentosa (RP) than in normal eyes and also shows correlation in logMAR visual acuity (VA), indicating it may be a predictor of VA in RP, according to a study published in the December 2006 issue of the American Journal of Ophthalmology.

Andre Witkin, MD from the New England Eye Center, Boston, USA and colleagues, conducted an observational case series of nine eyes of nine patients with RP and related diseases which were imaged using ultra-high resolution optical coherence tomography (UHR-OCT). Concurrently, 36 eyes of 36 normal subjects were also imaged this way. Central foveal thickness (CFT) and FOSPET were defined and measured on UHR-OCT images in all subjects and were compared between the two groups using unpaired t tests. The two thickness measurements in RP subjects were correlated with VA using Pearson correlation and linear regression.

The UHR-OCT images showed macular photoreceptor thinning in all RP subjects. The difference in CFT between the two groups was not statistically significant (p=0.103), however the difference in FOSPET was (p=0.003). VA showed some correlation with CFT (Pearson r=0.43, r2=0.187, p=0.245) and a strong correlation with FOSPET (Pearson r=0.942, r2=0.887, p<0.0001).

The researchers believe that FOSPET may represent a possible predictor of VA in patients with RP.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.